Article
Use of support vector machines for disease risk prediction in genome-wide association studies: concerns and opportunities.
Human mutation - 1 Dec 2012
Mittag Florian, Büchel Finja, Saad Mohamad, Jahn Andreas, Schulte Claudia, Bochdanovits Zoltan, Simón-Sánchez Javier, Nalls Mike A, Keller Margaux, Hernandez Dena G, Gibbs J Raphael, Lesage Suzanne, Brice Alexis, Heutink Peter, Martinez Maria, Wood Nicholas W, Hardy John, Singleton Andrew B, Zell Andreas, Gasser Thomas, Sharma Manu
Abstract excerpt
The success of genome-wide association studies (GWAS) in deciphering the genetic architecture of complex diseases has fueled the expectations whether the individual risk can also be quantified based on the genetic architecture. So far, disease risk prediction based on top-validated single-nucleotide polymorphisms (SNPs) showed little predictive value. Here, we applied a support vector machine (SVM) to Parkinson...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
